dopamine: be given for cardiovascular shock

Related concepts

Parents	neurotransmitter Weight: 0.73 , chemical Weight: 0.69 , hormone Weight: 0.68 , neuron Weight: 0.67 , drug Weight: 0.67
Siblings	acetylcholine Weight: 0.41 , serotonin Weight: 0.41 , vasopressin Weight: 0.39 , oxytocin Weight: 0.39 , norepinephrine Weight: 0.38

Related properties

Property	Similarity
be given for cardiovascular shock	1.00
be given for shock	0.84
be used in cardiogenic shock	0.83
be used in shock	0.80
be prefered over adrenaline in cardiogenic shock	0.78
be contraindicated in hypovolemic shock	0.77
be given for heart failure	0.77
be used in acute renal failure	0.76
be used in renal failure	0.76
be contraindicated in shock	0.76

Priors about this statement

Cues

Evidence

Clauses

Remarkability exclusitivity between siblings

0.10

Rule weight: 0.13
Evidence weight: 0.88
Similarity weight: 0.84

Evidence: 0.33

¬ Remarkable(dopamine, be given for cardiovascular shock) ⋁

Evidence: 0.37

¬ Remarkable(norepinephrine, be given for shock)

0.08

Rule weight: 0.13
Evidence weight: 0.73
Similarity weight: 0.80

Evidence: 0.33

¬ Remarkable(dopamine, be given for cardiovascular shock) ⋁

Evidence: 0.82

¬ Remarkable(vasopressin, be used in shock)

Remarkability from sibling implausibility

0.43

Rule weight: 0.60
Evidence weight: 0.90
Similarity weight: 0.80

Evidence: 0.41

Plausible(dopamine, be given for cardiovascular shock) ⋁

Evidence: 0.82

Remarkable(vasopressin, be used in shock) ⋁

Evidence: 0.94

¬ Plausible(vasopressin, be used in shock)

0.32

Rule weight: 0.60
Evidence weight: 0.63
Similarity weight: 0.84

Evidence: 0.41

Plausible(dopamine, be given for cardiovascular shock) ⋁

Evidence: 0.37

Remarkable(norepinephrine, be given for shock) ⋁

Evidence: 0.99

¬ Plausible(norepinephrine, be given for shock)

Salient implies Plausible

0.23

Rule weight: 0.28
Evidence weight: 0.80
Similarity weight: 1.00

Evidence: 0.41

Plausible(dopamine, be given for cardiovascular shock) ⋁

Evidence: 0.34

¬ Salient(dopamine, be given for cardiovascular shock)

Similarity expansion

0.63

Rule weight: 0.85
Evidence weight: 0.89
Similarity weight: 0.83

Evidence: 0.55

Typical(dopamine, be given for cardiovascular shock) ⋁

Evidence: 0.23

¬ Typical(dopamine, be used in cardiogenic shock)

0.58

Rule weight: 0.85
Evidence weight: 0.87
Similarity weight: 0.77

Evidence: 0.33

Remarkable(dopamine, be given for cardiovascular shock) ⋁

Evidence: 0.19

¬ Remarkable(dopamine, be given for heart failure)

0.56

Rule weight: 0.85
Evidence weight: 0.83
Similarity weight: 0.80

Evidence: 0.55

Typical(dopamine, be given for cardiovascular shock) ⋁

Evidence: 0.39

¬ Typical(dopamine, be used in shock)

0.56

Rule weight: 0.85
Evidence weight: 0.85
Similarity weight: 0.77

Evidence: 0.34

Salient(dopamine, be given for cardiovascular shock) ⋁

Evidence: 0.23

¬ Salient(dopamine, be given for heart failure)

0.56

Rule weight: 0.85
Evidence weight: 0.77
Similarity weight: 0.84

Evidence: 0.33

Remarkable(dopamine, be given for cardiovascular shock) ⋁

Evidence: 0.34

¬ Remarkable(dopamine, be given for shock)

0.54

Rule weight: 0.85
Evidence weight: 0.77
Similarity weight: 0.83

Evidence: 0.41

Plausible(dopamine, be given for cardiovascular shock) ⋁

Evidence: 0.39

¬ Plausible(dopamine, be used in cardiogenic shock)

0.54

Rule weight: 0.85
Evidence weight: 0.81
Similarity weight: 0.77

Evidence: 0.41

Plausible(dopamine, be given for cardiovascular shock) ⋁

Evidence: 0.31

¬ Plausible(dopamine, be given for heart failure)

0.51

Rule weight: 0.85
Evidence weight: 0.79
Similarity weight: 0.76

Evidence: 0.55

Typical(dopamine, be given for cardiovascular shock) ⋁

Evidence: 0.47

¬ Typical(dopamine, be used in renal failure)

0.51

Rule weight: 0.85
Evidence weight: 0.79
Similarity weight: 0.76

Evidence: 0.41

Plausible(dopamine, be given for cardiovascular shock) ⋁

Evidence: 0.36

¬ Plausible(dopamine, be used in renal failure)

0.51

Rule weight: 0.85
Evidence weight: 0.78
Similarity weight: 0.76

Evidence: 0.34

Salient(dopamine, be given for cardiovascular shock) ⋁

Evidence: 0.33

¬ Salient(dopamine, be used in renal failure)

0.50

Rule weight: 0.85
Evidence weight: 0.77
Similarity weight: 0.76

Evidence: 0.33

Remarkable(dopamine, be given for cardiovascular shock) ⋁

Evidence: 0.34

¬ Remarkable(dopamine, be used in acute renal failure)

0.50

Rule weight: 0.85
Evidence weight: 0.69
Similarity weight: 0.84

Evidence: 0.55

Typical(dopamine, be given for cardiovascular shock) ⋁

Evidence: 0.68

¬ Typical(dopamine, be given for shock)

0.50

Rule weight: 0.85
Evidence weight: 0.77
Similarity weight: 0.76

Evidence: 0.55

Typical(dopamine, be given for cardiovascular shock) ⋁

Evidence: 0.52

¬ Typical(dopamine, be contraindicated in shock)

0.50

Rule weight: 0.85
Evidence weight: 0.75
Similarity weight: 0.77

Evidence: 0.55

Typical(dopamine, be given for cardiovascular shock) ⋁

Evidence: 0.55

¬ Typical(dopamine, be contraindicated in hypovolemic shock)

0.50

Rule weight: 0.85
Evidence weight: 0.75
Similarity weight: 0.77

Evidence: 0.55

Typical(dopamine, be given for cardiovascular shock) ⋁

Evidence: 0.55

¬ Typical(dopamine, be given for heart failure)

0.49

Rule weight: 0.85
Evidence weight: 0.75
Similarity weight: 0.76

Evidence: 0.34

Salient(dopamine, be given for cardiovascular shock) ⋁

Evidence: 0.37

¬ Salient(dopamine, be used in acute renal failure)

0.49

Rule weight: 0.85
Evidence weight: 0.75
Similarity weight: 0.76

Evidence: 0.33

Remarkable(dopamine, be given for cardiovascular shock) ⋁

Evidence: 0.38

¬ Remarkable(dopamine, be used in renal failure)

0.48

Rule weight: 0.85
Evidence weight: 0.73
Similarity weight: 0.76

Evidence: 0.41

Plausible(dopamine, be given for cardiovascular shock) ⋁

Evidence: 0.45

¬ Plausible(dopamine, be used in acute renal failure)

0.48

Rule weight: 0.85
Evidence weight: 0.73
Similarity weight: 0.76

Evidence: 0.55

Typical(dopamine, be given for cardiovascular shock) ⋁

Evidence: 0.59

¬ Typical(dopamine, be used in acute renal failure)

0.46

Rule weight: 0.85
Evidence weight: 0.64
Similarity weight: 0.84

Evidence: 0.34

Salient(dopamine, be given for cardiovascular shock) ⋁

Evidence: 0.54

¬ Salient(dopamine, be given for shock)

0.44

Rule weight: 0.85
Evidence weight: 0.62
Similarity weight: 0.83

Evidence: 0.34

Salient(dopamine, be given for cardiovascular shock) ⋁

Evidence: 0.58

¬ Salient(dopamine, be used in cardiogenic shock)

0.43

Rule weight: 0.85
Evidence weight: 0.66
Similarity weight: 0.76

Evidence: 0.41

Plausible(dopamine, be given for cardiovascular shock) ⋁

Evidence: 0.58

¬ Plausible(dopamine, be contraindicated in shock)

0.43

Rule weight: 0.85
Evidence weight: 0.65
Similarity weight: 0.77

Evidence: 0.41

Plausible(dopamine, be given for cardiovascular shock) ⋁

Evidence: 0.60

¬ Plausible(dopamine, be contraindicated in hypovolemic shock)

0.40

Rule weight: 0.85
Evidence weight: 0.61
Similarity weight: 0.78

Evidence: 0.33

Remarkable(dopamine, be given for cardiovascular shock) ⋁

Evidence: 0.59

¬ Remarkable(dopamine, be prefered over adrenaline in cardiogenic shock)

0.40

Rule weight: 0.85
Evidence weight: 0.60
Similarity weight: 0.78

Evidence: 0.55

Typical(dopamine, be given for cardiovascular shock) ⋁

Evidence: 0.90

¬ Typical(dopamine, be prefered over adrenaline in cardiogenic shock)

0.39

Rule weight: 0.85
Evidence weight: 0.57
Similarity weight: 0.80

Evidence: 0.34

Salient(dopamine, be given for cardiovascular shock) ⋁

Evidence: 0.64

¬ Salient(dopamine, be used in shock)

0.35

Rule weight: 0.85
Evidence weight: 0.51
Similarity weight: 0.80

Evidence: 0.33

Remarkable(dopamine, be given for cardiovascular shock) ⋁

Evidence: 0.73

¬ Remarkable(dopamine, be used in shock)

0.34

Rule weight: 0.85
Evidence weight: 0.52
Similarity weight: 0.76

Evidence: 0.34

Salient(dopamine, be given for cardiovascular shock) ⋁

Evidence: 0.73

¬ Salient(dopamine, be contraindicated in shock)

0.33

Rule weight: 0.85
Evidence weight: 0.50
Similarity weight: 0.78

Evidence: 0.41

Plausible(dopamine, be given for cardiovascular shock) ⋁

Evidence: 0.85

¬ Plausible(dopamine, be prefered over adrenaline in cardiogenic shock)

0.33

Rule weight: 0.85
Evidence weight: 0.50
Similarity weight: 0.77

Evidence: 0.34

Salient(dopamine, be given for cardiovascular shock) ⋁

Evidence: 0.75

¬ Salient(dopamine, be contraindicated in hypovolemic shock)

0.33

Rule weight: 0.85
Evidence weight: 0.48
Similarity weight: 0.80

Evidence: 0.41

Plausible(dopamine, be given for cardiovascular shock) ⋁

Evidence: 0.88

¬ Plausible(dopamine, be used in shock)

0.33

Rule weight: 0.85
Evidence weight: 0.45
Similarity weight: 0.84

Evidence: 0.41

Plausible(dopamine, be given for cardiovascular shock) ⋁

Evidence: 0.93

¬ Plausible(dopamine, be given for shock)

0.31

Rule weight: 0.85
Evidence weight: 0.48
Similarity weight: 0.77

Evidence: 0.33

Remarkable(dopamine, be given for cardiovascular shock) ⋁

Evidence: 0.78

¬ Remarkable(dopamine, be contraindicated in hypovolemic shock)

0.31

Rule weight: 0.85
Evidence weight: 0.47
Similarity weight: 0.76

Evidence: 0.33

Remarkable(dopamine, be given for cardiovascular shock) ⋁

Evidence: 0.79

¬ Remarkable(dopamine, be contraindicated in shock)

0.30

Rule weight: 0.85
Evidence weight: 0.43
Similarity weight: 0.83

Evidence: 0.33

Remarkable(dopamine, be given for cardiovascular shock) ⋁

Evidence: 0.86

¬ Remarkable(dopamine, be used in cardiogenic shock)

0.27

Rule weight: 0.85
Evidence weight: 0.40
Similarity weight: 0.78

Evidence: 0.34

Salient(dopamine, be given for cardiovascular shock) ⋁

Evidence: 0.90

¬ Salient(dopamine, be prefered over adrenaline in cardiogenic shock)

Typical and Remarkable implies Salient

0.12

Rule weight: 0.14
Evidence weight: 0.88
Similarity weight: 1.00

Evidence: 0.34

Salient(dopamine, be given for cardiovascular shock) ⋁

Evidence: 0.55

¬ Typical(dopamine, be given for cardiovascular shock) ⋁

Evidence: 0.33

¬ Remarkable(dopamine, be given for cardiovascular shock)

Typical implies Plausible

0.32

Rule weight: 0.48
Evidence weight: 0.68
Similarity weight: 1.00

Evidence: 0.41

Plausible(dopamine, be given for cardiovascular shock) ⋁

Evidence: 0.55

¬ Typical(dopamine, be given for cardiovascular shock)

Typicality and Rermarkability incompatibility between siblings

0.09

Rule weight: 0.14
Evidence weight: 0.85
Similarity weight: 0.80

Evidence: 0.33

¬ Remarkable(dopamine, be given for cardiovascular shock) ⋁

Evidence: 0.46

¬ Typical(vasopressin, be used in shock)

0.08

Rule weight: 0.14
Evidence weight: 0.69
Similarity weight: 0.84

Evidence: 0.33

¬ Remarkable(dopamine, be given for cardiovascular shock) ⋁

Evidence: 0.93

¬ Typical(norepinephrine, be given for shock)